Back
ProQR Therapeutics NV Vs. NovoCure Ltd. Industry Stock Comparison
Buy
59
PRQR
ProQR Therapeutics NV
Last Price:
$2.03
Seasonality Move:
13.33%
Sell
47
NVCR
NovoCure Ltd.
Last Price:
$13.27
Seasonality Move:
-11.88%
Buy
59
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
-
The current ProQR Therapeutics NV [PRQR] share price is $2.17. The Score for PRQR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. a Buy, Sell or Hold?
-
The current NovoCure Ltd. [NVCR] share price is $13.48. The Score for NVCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $2.17The current trend is moderately bullish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Stock Price Chart
What is NovoCure Ltd.'s stock price today?
-
The NovoCure Ltd. share price today is $13.48The current trend is moderately bullish and NVCR is experiencing slight buying pressure.
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 47.75 | Sell |
| Chaikin Money Flow: | -590201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.31) | Sell |
| Bollinger Bands (100): | (2.03 - 2.53) | Sell |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 59.07 | Buy |
| Chaikin Money Flow: | 273679 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.89 - 13.29) | Buy |
| Bollinger Bands (100): | (11.65 - 13.53) | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.18 | Sell |
| 20-day SMA: | 2.19 | Sell |
| 50-day SMA: | 2.35 | Sell |
| 200-day SMA: | 2.02 | Buy |
| 8-day EMA: | 1.8 | Buy |
| 20-day EMA: | 1.09 | Buy |
| 50-day EMA: | 0.53 | Buy |
| 200-day EMA: | 0.15 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.04 | Buy |
| 20-day SMA: | 12.67 | Buy |
| 50-day SMA: | 12.56 | Buy |
| 200-day SMA: | 14.83 | Sell |
| 8-day EMA: | 13.17 | Buy |
| 20-day EMA: | 12.82 | Buy |
| 50-day EMA: | 12.7 | Buy |
| 200-day EMA: | 14.82 | Sell |
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.08 per share.
NovoCure Ltd. Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.10 per share.
ProQR Therapeutics NV Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Ltd. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||